SrasV1, PascalFrancis, Curation, bibRecord, 000143

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Identifieur interne : 000143 ( PascalFrancis/Curation ); précédent : 000142; suivant : 000144

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Auteurs : Chang-Jer Wu [Taïwan] ; Jia-Tsrong Jan [Taïwan] ; Chi-Min Chen [Taïwan] ; Hsing-Pang Hsieh [Taïwan] ; Der-Ren Hwang [Taïwan] ; Hwan-Wun Liu [Taïwan] ; Chiu-Yi Liu [Taïwan] ; Hui-Wen Huang [Taïwan] ; Su-Chin Chen [Taïwan] ; Cheng-Fong Hong [Taïwan] ; Ren-Kuo Lin [Taïwan] ; Yu-Sheng Chao [Taïwan] ; John T. A. Hsu [Taïwan]

Source :

Antimicrobial agents and chemotherapy [ 0066-4804 ] ; 2004.

RBID : Pascal:04-0389847

Descripteurs français

Pascal (Inist)
- Niclosamide, Syndrome respiratoire aigu sévère, Coronavirus, Réplication, Antiparasitaire, Anthelminthique.

English descriptors

KwdEn :
- Anthelmintic, Coronavirus, Niclosamide, Parasiticide, Replication, Severe acute respiratory syndrome.

Abstract

Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.

A01	`01`	`1`		`@0 0066-4804`
A02	`01`			`@0 AACHAX`
A03		`1`		`@0 Antimicrob. agents chemother.`
A05				`@2 48`
A06				`@2 7`
A08	`01`	`1`	`ENG`	`@1 Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide`
A11	`01`	`1`		`@1 WU (Chang-Jer)`
A11	`02`	`1`		`@1 JAN (Jia-Tsrong)`
A11	`03`	`1`		`@1 CHEN (Chi-Min)`
A11	`04`	`1`		`@1 HSIEH (Hsing-Pang)`
A11	`05`	`1`		`@1 HWANG (Der-Ren)`
A11	`06`	`1`		`@1 LIU (Hwan-Wun)`
A11	`07`	`1`		`@1 LIU (Chiu-Yi)`
A11	`08`	`1`		`@1 HUANG (Hui-Wen)`
A11	`09`	`1`		`@1 CHEN (Su-Chin)`
A11	`10`	`1`		`@1 HONG (Cheng-Fong)`
A11	`11`	`1`		`@1 LIN (Ren-Kuo)`
A11	`12`	`1`		`@1 CHAO (Yu-Sheng)`
A11	`13`	`1`		`@1 HSU (John T. A.)`
A14	`01`			`@1 Institute of Preventive Medicine, National Defense Medical College, National Defense University @2 Taipei @3 TWN @Z 1 aut. @Z 2 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut. @Z 9 aut. @Z 10 aut.`
A14	`02`			`@1 Animal Technology Institute Taiwan @2 Miaoli @3 TWN @Z 3 aut.`
A14	`03`			`@1 Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes @2 Taipei @3 TWN @Z 4 aut. @Z 5 aut. @Z 11 aut. @Z 12 aut. @Z 13 aut.`
A20				`@1 2693-2696`
A21				`@1 2004`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 13334 @5 354000113669200490`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 9 ref.`
A47	`01`	`1`		`@0 04-0389847`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Antimicrobial agents and chemotherapy`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.`
C02	`01`	`X`		`@0 002B02S`
C03	`01`	`X`	`FRE`	`@0 Niclosamide @2 NK @2 FR @5 01`
C03	`01`	`X`	`ENG`	`@0 Niclosamide @2 NK @2 FR @5 01`
C03	`01`	`X`	`SPA`	`@0 Niclosamida @2 NK @2 FR @5 01`
C03	`02`	`X`	`FRE`	`@0 Syndrome respiratoire aigu sévère @2 NM @5 11`
C03	`02`	`X`	`ENG`	`@0 Severe acute respiratory syndrome @2 NM @5 11`
C03	`02`	`X`	`SPA`	`@0 Síndrome respiratorio agudo severo @2 NM @5 11`
C03	`03`	`X`	`FRE`	`@0 Coronavirus @2 NW @5 12`
C03	`03`	`X`	`ENG`	`@0 Coronavirus @2 NW @5 12`
C03	`03`	`X`	`SPA`	`@0 Coronavirus @2 NW @5 12`
C03	`04`	`X`	`FRE`	`@0 Réplication @5 14`
C03	`04`	`X`	`ENG`	`@0 Replication @5 14`
C03	`04`	`X`	`SPA`	`@0 Replicación @5 14`
C03	`05`	`X`	`FRE`	`@0 Antiparasitaire @5 15`
C03	`05`	`X`	`ENG`	`@0 Parasiticide @5 15`
C03	`05`	`X`	`SPA`	`@0 Antiparasitario @5 15`
C03	`06`	`X`	`FRE`	`@0 Anthelminthique @5 16`
C03	`06`	`X`	`ENG`	`@0 Anthelmintic @5 16`
C03	`06`	`X`	`SPA`	`@0 Antihelmíntico @5 16`
C07	`01`	`X`	`FRE`	`@0 Virose @2 NM`
C07	`01`	`X`	`ENG`	`@0 Viral disease @2 NM`
C07	`01`	`X`	`SPA`	`@0 Virosis @2 NM`
C07	`02`	`X`	`FRE`	`@0 Infection @2 NM`
C07	`02`	`X`	`ENG`	`@0 Infection @2 NM`
C07	`02`	`X`	`SPA`	`@0 Infección @2 NM`
C07	`03`	`X`	`FRE`	`@0 Coronaviridae @2 NW`
C07	`03`	`X`	`ENG`	`@0 Coronaviridae @2 NW`
C07	`03`	`X`	`SPA`	`@0 Coronaviridae @2 NW`
C07	`04`	`X`	`FRE`	`@0 Nidovirales @2 NW`
C07	`04`	`X`	`ENG`	`@0 Nidovirales @2 NW`
C07	`04`	`X`	`SPA`	`@0 Nidovirales @2 NW`
C07	`05`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`05`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`05`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`06`	`X`	`FRE`	`@0 Appareil respiratoire pathologie @5 61`
C07	`06`	`X`	`ENG`	`@0 Respiratory disease @5 61`
C07	`06`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 61`
C07	`07`	`X`	`FRE`	`@0 Poumon pathologie @5 62`
C07	`07`	`X`	`ENG`	`@0 Lung disease @5 62`
C07	`07`	`X`	`SPA`	`@0 Pulmón patología @5 62`
N21				`@1 222`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000847

Links to Exploration step

Pascal:04-0389847

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide</title>
<author><name sortKey="Wu, Chang Jer" sort="Wu, Chang Jer" uniqKey="Wu C" first="Chang-Jer" last="Wu">Chang-Jer Wu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Jan, Jia Tsrong" sort="Jan, Jia Tsrong" uniqKey="Jan J" first="Jia-Tsrong" last="Jan">Jia-Tsrong Jan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chen, Chi Min" sort="Chen, Chi Min" uniqKey="Chen C" first="Chi-Min" last="Chen">Chi-Min Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Animal Technology Institute Taiwan</s1>
<s2>Miaoli</s2>
<s3>TWN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hsieh, Hsing Pang" sort="Hsieh, Hsing Pang" uniqKey="Hsieh H" first="Hsing-Pang" last="Hsieh">Hsing-Pang Hsieh</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hwang, Der Ren" sort="Hwang, Der Ren" uniqKey="Hwang D" first="Der-Ren" last="Hwang">Der-Ren Hwang</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Liu, Hwan Wun" sort="Liu, Hwan Wun" uniqKey="Liu H" first="Hwan-Wun" last="Liu">Hwan-Wun Liu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Liu, Chiu Yi" sort="Liu, Chiu Yi" uniqKey="Liu C" first="Chiu-Yi" last="Liu">Chiu-Yi Liu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Huang, Hui Wen" sort="Huang, Hui Wen" uniqKey="Huang H" first="Hui-Wen" last="Huang">Hui-Wen Huang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chen, Su Chin" sort="Chen, Su Chin" uniqKey="Chen S" first="Su-Chin" last="Chen">Su-Chin Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hong, Cheng Fong" sort="Hong, Cheng Fong" uniqKey="Hong C" first="Cheng-Fong" last="Hong">Cheng-Fong Hong</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Lin, Ren Kuo" sort="Lin, Ren Kuo" uniqKey="Lin R" first="Ren-Kuo" last="Lin">Ren-Kuo Lin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chao, Yu Sheng" sort="Chao, Yu Sheng" uniqKey="Chao Y" first="Yu-Sheng" last="Chao">Yu-Sheng Chao</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hsu, John T A" sort="Hsu, John T A" uniqKey="Hsu J" first="John T. A." last="Hsu">John T. A. Hsu</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0389847</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0389847 INIST</idno>
<idno type="RBID">Pascal:04-0389847</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000847</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000143</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide</title>
<author><name sortKey="Wu, Chang Jer" sort="Wu, Chang Jer" uniqKey="Wu C" first="Chang-Jer" last="Wu">Chang-Jer Wu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Jan, Jia Tsrong" sort="Jan, Jia Tsrong" uniqKey="Jan J" first="Jia-Tsrong" last="Jan">Jia-Tsrong Jan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chen, Chi Min" sort="Chen, Chi Min" uniqKey="Chen C" first="Chi-Min" last="Chen">Chi-Min Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Animal Technology Institute Taiwan</s1>
<s2>Miaoli</s2>
<s3>TWN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hsieh, Hsing Pang" sort="Hsieh, Hsing Pang" uniqKey="Hsieh H" first="Hsing-Pang" last="Hsieh">Hsing-Pang Hsieh</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hwang, Der Ren" sort="Hwang, Der Ren" uniqKey="Hwang D" first="Der-Ren" last="Hwang">Der-Ren Hwang</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Liu, Hwan Wun" sort="Liu, Hwan Wun" uniqKey="Liu H" first="Hwan-Wun" last="Liu">Hwan-Wun Liu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Liu, Chiu Yi" sort="Liu, Chiu Yi" uniqKey="Liu C" first="Chiu-Yi" last="Liu">Chiu-Yi Liu</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Huang, Hui Wen" sort="Huang, Hui Wen" uniqKey="Huang H" first="Hui-Wen" last="Huang">Hui-Wen Huang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chen, Su Chin" sort="Chen, Su Chin" uniqKey="Chen S" first="Su-Chin" last="Chen">Su-Chin Chen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hong, Cheng Fong" sort="Hong, Cheng Fong" uniqKey="Hong C" first="Cheng-Fong" last="Hong">Cheng-Fong Hong</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Lin, Ren Kuo" sort="Lin, Ren Kuo" uniqKey="Lin R" first="Ren-Kuo" last="Lin">Ren-Kuo Lin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Chao, Yu Sheng" sort="Chao, Yu Sheng" uniqKey="Chao Y" first="Yu-Sheng" last="Chao">Yu-Sheng Chao</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
<author><name sortKey="Hsu, John T A" sort="Hsu, John T A" uniqKey="Hsu J" first="John T. A." last="Hsu">John T. A. Hsu</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Taïwan</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Antimicrobial agents and chemotherapy</title>
<title level="j" type="abbreviated">Antimicrob. agents chemother.</title>
<idno type="ISSN">0066-4804</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Antimicrobial agents and chemotherapy</title>
<title level="j" type="abbreviated">Antimicrob. agents chemother.</title>
<idno type="ISSN">0066-4804</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthelmintic</term>
<term>Coronavirus</term>
<term>Niclosamide</term>
<term>Parasiticide</term>
<term>Replication</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Niclosamide</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Coronavirus</term>
<term>Réplication</term>
<term>Antiparasitaire</term>
<term>Anthelminthique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0066-4804</s0>
</fA01>
<fA02 i1="01"><s0>AACHAX</s0>
</fA02>
<fA03 i2="1"><s0>Antimicrob. agents chemother.</s0>
</fA03>
<fA05><s2>48</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WU (Chang-Jer)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JAN (Jia-Tsrong)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHEN (Chi-Min)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HSIEH (Hsing-Pang)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HWANG (Der-Ren)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LIU (Hwan-Wun)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>LIU (Chiu-Yi)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HUANG (Hui-Wen)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHEN (Su-Chin)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>HONG (Cheng-Fong)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>LIN (Ren-Kuo)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>CHAO (Yu-Sheng)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>HSU (John T. A.)</s1>
</fA11>
<fA14 i1="01"><s1>Institute of Preventive Medicine, National Defense Medical College, National Defense University</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Animal Technology Institute Taiwan</s1>
<s2>Miaoli</s2>
<s3>TWN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes</s1>
<s2>Taipei</s2>
<s3>TWN</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA20><s1>2693-2696</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>13334</s2>
<s5>354000113669200490</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0389847</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Antimicrobial agents and chemotherapy</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02S</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Niclosamide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Niclosamide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Niclosamida</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>12</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>12</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>12</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Réplication</s0>
<s5>14</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Replication</s0>
<s5>14</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Replicación</s0>
<s5>14</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Antiparasitaire</s0>
<s5>15</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Parasiticide</s0>
<s5>15</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Antiparasitario</s0>
<s5>15</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Anthelminthique</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Anthelmintic</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Antihelmíntico</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Poumon pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>62</s5>
</fC07>
<fN21><s1>222</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000143 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000143 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0389847
   |texte=   Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri